KFO 342 - P2: How VE-PTP and Tie-2 regulate endothelial cell junctions in VE-cadherin dependent and independent ways

Basic data for this project

Type of projectSubproject in DFG-joint project hosted at University of Münster
Duration at the University of Münster01/10/2019 - 30/09/2023 | 1st Funding period

Description

The endothelial specific Vascular Endothelial Protein Tyrosine Phosphatase (VE-PTP) is a receptor type tyrosine phosphatase (R-PTP) which is a major regulator of endothelial junctions, vascular permeability and leukocyte extravasation. We have shown that this phosphatase associates with and regulates the function of VE-cadherin, an adhesion molecule, which is of central importance for the integrity of endothelial junctions. In addition, we found that VE-PTP regulates the activity of the tyrosine kinase receptor Tie-2, which stabilizes junctions. Consequently, VE-PTP is a valuable pharmacological target for the stabilization of endothelial junctions and for the inhibition of inflammation induced vascular leak formation. Indeed, the highly specific inhibitor of VE-PTP, AKB9778, is able to protect from leak formation in inflammation models in the mouse and is presently tested successfully in phase II trials on diabetic retinopathy in patients. The purpose of this proposal is to elucidate the detailed mechanisms by which the inhibition of VE-PTP supports vascular integrity. We will analyze how the effects of VE-PTP on Tie-2 and VE-cadherin relate to each other and which other substrates and signaling targets of VE-PTP are involved in the regulation of endothelial junctions.

KeywordsAnaesthesiology; Molecular Biomedicine
Website of the projecthttps://kfo342.de/en/project/p2/
Funder / funding scheme
  • DFG - Clinical Research Unit (KFO)

Project management at the University of Münster

Vestweber, Dietmar
Max Planck Institute for Molecular Biomedicine

Applicants from the University of Münster

Vestweber, Dietmar
Max Planck Institute for Molecular Biomedicine